PMID- 31748944
OWN - NLM
STAT- MEDLINE
DCOM- 20200511
LR  - 20200511
IS  - 1539-0829 (Electronic)
IS  - 1534-4827 (Linking)
VI  - 19
IP  - 11
DP  - 2019 Nov 20
TI  - Patient-Reported Outcome Measures in Registry-Based Studies of Type 2 Diabetes 
      Mellitus: a Systematic Review.
PG  - 135
LID - 10.1007/s11892-019-1265-8 [doi]
AB  - PURPOSE OF REVIEW: Patient-reported outcome measures (PROMs) and patient 
      registries both play important roles in assessing patient outcomes. However, no 
      study has examined the use of PROMs among registries involving patients with type 
      2 diabetes mellitus (T2DM). Our objective is twofold: first, to review the range 
      of PROMs used in registry-based studies of patients with T2DM; second, to 
      describe associations between these PROMs, T2DM and its complications. RECENT 
      FINDINGS: The International Consortium for Health Outcomes Measurement (ICHOM) 
      Diabetes Standard Set recommended routine usage of PROMs to assess psychological 
      well-being, diabetes distress, and depression among patients with T2DM. A wide 
      variety of PROMs were used among the 15 studies included in this review. Quality 
      of life, depressive symptoms and treatment adherence were the most common aspects 
      of T2DM that utilised PROMs for assessment. Adoption of PROMs among registries of 
      patients with T2DM remains uncommon, non-routine and with few that are validated 
      before use.
FAU - Chen, Yu Ting
AU  - Chen YT
AD  - Saw Swee Hock School of Public Health, National University of Singapore, 12 
      Science Drive 2, Singapore, 117549, Singapore.
FAU - Tan, Yan Zhi
AU  - Tan YZ
AD  - Department of Health Management and Economics, University of Oslo, Kirkeveien 
      166, Frederik Holsts hus , 0450, Oslo, Norway.
AD  - Erasmus School of Health Policy & Management, Erasmus University Rotterdam, 
      Burgemeester Oudlaan 50 , Rotterdam, PA, 3062, Netherlands.
FAU - Cheen, Mcvin
AU  - Cheen M
AD  - Danone Asia Pacific Holdings, 1 Wallich Street, #18-01 Guoco Tower, Singapore, 
      078881, Singapore.
AD  - Medicine Academic Clinical Programme, Duke-NUS Medical School, 8 College Rd, 
      Singapore, 169857, Singapore.
FAU - Wee, Hwee-Lin
AU  - Wee HL
AD  - Saw Swee Hock School of Public Health, National University of Singapore, 12 
      Science Drive 2, Singapore, 117549, Singapore. ephwhl@nus.edu.sg.
AD  - Department of Pharmacy, Faculty of Science, National University of Singapore, 18 
      Science Drive 4, Singapore, 117543, Singapore. ephwhl@nus.edu.sg.
LA  - eng
PT  - Journal Article
PT  - Systematic Review
DEP - 20191120
PL  - United States
TA  - Curr Diab Rep
JT  - Current diabetes reports
JID - 101093791
SB  - IM
MH  - Adult
MH  - Aged
MH  - Canada
MH  - Cross-Sectional Studies
MH  - *Diabetes Mellitus, Type 2/drug therapy
MH  - Humans
MH  - Middle Aged
MH  - *Patient Reported Outcome Measures
MH  - *Quality of Life
MH  - *Registries
OTO - NOTNLM
OT  - Depressive symptoms
OT  - Diabetes mellitus
OT  - Patient-reported outcome measures
OT  - Quality of life
OT  - Registries
OT  - Treatment adherence
EDAT- 2019/11/22 06:00
MHDA- 2020/05/12 06:00
CRDT- 2019/11/22 06:00
PHST- 2019/11/22 06:00 [entrez]
PHST- 2019/11/22 06:00 [pubmed]
PHST- 2020/05/12 06:00 [medline]
AID - 10.1007/s11892-019-1265-8 [pii]
AID - 10.1007/s11892-019-1265-8 [doi]
PST - epublish
SO  - Curr Diab Rep. 2019 Nov 20;19(11):135. doi: 10.1007/s11892-019-1265-8.